Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cumberland Pharmaceuticals (CPIX) Return on Assets (2016 - 2025)

Historic Return on Assets for Cumberland Pharmaceuticals (CPIX) over the last 17 years, with Q3 2025 value amounting to 0.05%.

  • Cumberland Pharmaceuticals' Return on Assets rose 900.0% to 0.05% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.05%, marking a year-over-year increase of 900.0%. This contributed to the annual value of 0.08% for FY2024, which is 100.0% down from last year.
  • According to the latest figures from Q3 2025, Cumberland Pharmaceuticals' Return on Assets is 0.05%, which was up 900.0% from 0.04% recorded in Q2 2025.
  • Over the past 5 years, Cumberland Pharmaceuticals' Return on Assets peaked at 0.03% during Q1 2021, and registered a low of 0.14% during Q3 2024.
  • For the 5-year period, Cumberland Pharmaceuticals' Return on Assets averaged around 0.03%, with its median value being 0.0% (2023).
  • As far as peak fluctuations go, Cumberland Pharmaceuticals' Return on Assets crashed by -1400bps in 2024, and later surged by 900bps in 2025.
  • Over the past 5 years, Cumberland Pharmaceuticals' Return on Assets (Quarter) stood at 0.02% in 2021, then tumbled by -76bps to 0.01% in 2022, then crashed by -1460bps to 0.07% in 2023, then fell by -13bps to 0.08% in 2024, then skyrocketed by 41bps to 0.05% in 2025.
  • Its Return on Assets stands at 0.05% for Q3 2025, versus 0.04% for Q2 2025 and 0.05% for Q1 2025.